Daxor (DXR)
(Delayed Data from NSDQ)
$9.00 USD
+0.15 (1.70%)
Updated Jun 14, 2024 10:25 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Daxor Corporation [DXR]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
Optimized Entry and Exit Levels for DXR 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
We initiate coverage with a Neutral rating and an $18/share price target
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
Downside risk should be limited due to the company?s investment portfolio
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
Downside risk should be limited due to the company?s investment portfolio
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: Daxor Corporation
Industry: Medical - Outpatient and Home Healthcare
We are initiating coverage of Daxor Corporation (DXR).
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
|